Why Older Adults Get Less Protection From Flu and Shingles Vaccines
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
420 articles
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
A completed trial tested whether probiotic and prebiotic supplementation could reduce premature aging-related inflammation in people living with HIV.
A Phase 1 trial examines whether Botulinum toxin in the glabella and forehead lifts mood and self-appearance satisfaction in returning Botox patients.
A 12-week RCT compares HIIT and combined endurance-strength training on oxidative stress, inflammation, and cardiometabolic risk in obese postmenopausal women.
Baylor researchers investigated whether glutathione precursors glycine and NAC could reverse oxidative stress and mitochondrial dysfunction in COVID-19.
NCI-sponsored trial evaluates safety and optimal dosing of immune checkpoint blockade following standard chemoradiation in locally advanced cervical cancer.
A Phase 2 trial evaluates MBA-P01, a novel botulinum toxin A, for safety and optimal dosing in treating frown lines.
A Phase 1/2 trial tests whether combining durvalumab, tremelimumab, and FOLFOX chemotherapy can safely boost immune response in mCRC.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A Swiss feasibility trial tests digital mindfulness-based cancer recovery, tracking psychosocial outcomes, medication use, and biological markers.
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.